1. PO-099 Managing recurrent/metastatic head and neck cancer in the real-world: Paclitaxel plus Cetuximab. (March 2019) Authors: Leão, I.; Neto, R.; Marinho, J.; Neto, E.; Dias, E.; Joaquim, A. Journal: Radiotherapy and oncology Issue: Volume 132(2019)Supplement 1 Page Start: 51 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. PO-1145 IORT for Brain Metastases: Final First-Stage Results of a Single-Arm, Open-Label, Phase 2 Trial. (May 2022) Authors: Castro, D.; Sanematsu, P.; Pellizzon, A.C.; Suzuki, S.; Fogaroli, R.; Dias, J.E.; Gondim, G.; Estrada, D.; Silva, M.L.; Rassi, M.; Chen, M.; Giacomelli, R.; Ramos, H.; Neto, E.; Abrahão, C.; Coelho, T.; Yu, L.; Tannous, C.; Calsavara, V.; Giordano, F. Journal: Radiotherapy and oncology Issue: Volume 170(2022)Supplement 1 Page Start: S971 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. PO-1294 clinical prognostic factors for esophageal cancer treated with definitive chemo-radiotherapy. (May 2022) Authors: Favareto, S.; Sousa, C.; Pinto, P.; Ramos, H.; Neto, E.; Abrahao, C.; Chen, M.; Pellizzon, A.C.; Silva, M.L.; Gondim, G.; Castro, D.; Fogaroli, R. Journal: Radiotherapy and oncology Issue: Volume 170(2022)Supplement 1 Page Start: S1091 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗